LAUSR

Lead is one of the major environmental pollutions worldwide, particularly in developing countries. Though, various occupational and public health measures have been undertaken to control lead exposure. The present study is designed to investigate the role of zinc oxide nanoparticles (ZnO-NPs) to reduce the bioaggregation of lead in the brain, liver, and kidneys and prevent these organ oxidative damage and apoptosis. Twenty male Wistar rats were grouped into 4 gatherings and exposed to the following materials daily on the skin for 2 weeks: 1—normal saline, 2—ZnO-NPs, 3—PbO, and 4—ZnO-NPs+ PbO. Topical application of PbO to rats increased lead contents in blood and different organs causing remarkable oxidative stress damage, apoptosis, and histopathological alterations in these organs. Moreover, PbO-receiving group showed strong positive caspase-3 protein expression with up-regulation of mRNA levels of BAX and COX-2. Co-treatment of ZnO-NPs with PbO could diminish the toxicologic parameters and the above-mentioned immune marker and gene expression levels. Our data suggest the role of ZnO-NPs cream to reduce the risk of lead dermal exposure via preventing absorption and accumulation of it in the internal organs so that it protects these organs from further damage.